|
Volumn 45, Issue RR-11, 1996, Pages 1-36
|
Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
ANTISERUM;
ANTIVIRUS AGENT;
CHICKENPOX VACCINE;
LIVE VACCINE;
VARICELLA ZOSTER IMMUNE GLOBULIN;
VARICELLA-ZOSTER IMMUNE GLOBULIN;
VIRUS ANTIBODY;
VIRUS VACCINE;
ADOLESCENT;
ADULT;
AGE DISTRIBUTION;
AGED;
ARTICLE;
CHICKENPOX;
CHILD;
COST BENEFIT ANALYSIS;
CROSS INFECTION;
DISEASE TRANSMISSION;
DRUG CONTRAINDICATION;
DRUG STORAGE;
ECONOMICS;
FEMALE;
HERPES ZOSTER;
HUMAN;
IMMUNOLOGY;
INCIDENCE;
INFANT;
MIDDLE AGED;
NEWBORN;
PASSIVE IMMUNIZATION;
POSTMARKETING SURVEILLANCE;
PRACTICE GUIDELINE;
PREGNANCY;
PRESCHOOL CHILD;
SEROLOGY;
STANDARD;
VACCINATION;
VARICELLA ZOSTER VIRUS;
ACYCLOVIR;
ADOLESCENT;
ADULT;
AGE DISTRIBUTION;
AGED;
ANTIBODIES, VIRAL;
ANTIVIRAL AGENTS;
CHICKENPOX;
CHICKENPOX VACCINE;
CHILD;
CHILD, PRESCHOOL;
COST-BENEFIT ANALYSIS;
CROSS INFECTION;
DRUG STORAGE;
FEMALE;
HERPES ZOSTER;
HERPESVIRUS 3, HUMAN;
HUMANS;
IMMUNE SERA;
IMMUNIZATION, PASSIVE;
INCIDENCE;
INFANT;
INFANT, NEWBORN;
MIDDLE AGED;
PREGNANCY;
PRODUCT SURVEILLANCE, POSTMARKETING;
SEROLOGIC TESTS;
VACCINATION;
VACCINES, ATTENUATED;
VIRAL VACCINES;
|
EID: 0030581083
PISSN: 10575987
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (294)
|
References (0)
|